|Description||SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus 2) also known as 2019-nCoV (2019 Novel Coronavirus) is a virus that cause severe respiratory illness. SARS-CoV-2 Spike Protein is derived from 2019-nCoV, which is composed of a S1 domain and S2 domain. The S1 contains a receptor-binding domain (RBD) that can specifically bind to angiotensin-converting enzyme 2 (ACE2), the receptor on target cells. It is believed that SARS-CoV-2 Spike Protein (RBD) has potential value for the diagnosis of the virus.
To further study the Spike protein of SARS-CoV-2, GenScript developed and successfully established a stable cell line, which can stably overexpress the Spike protein of SARS-CoV-2.
|Culture Medium||F-12K, 10% FBS, 8 μg/ml Puromycin|
|Freeze Medium||95% complete growth medium, 5% DMSO|
|Storage||Liquid nitrogen immediately upon receiving|
|In Vitro binding assay or used as immunogen
For more documents, please visit "Technical Support".
|Cat. No. M00803|
20% off your first order! Offer valid till December 31st, 2020.